Fundz

Imara Inc. reported raising $44.1 Million in an initial SEC Form D filing, from an offering of $63 Million

PUBLIC · ELVNMar 29, 2019$44.1M of $63M raised

Amount Raised

$44.1 Million

$44.1 Million sold, per SEC Form D (first sale Mar 29, 2019)

Round Type

Venture

BurlingameBiotechnologyHealthcareHealth CareScience And EngineeringTherapeutics

Quick answer

Enliven Therapeutics raised $44.1 Million in a funding round, dated March 29, 2019. Enliven Therapeutics is based in Burlingame, California, United States.

How much did Enliven Therapeutics raise?
Enliven Therapeutics raised $44.1 Million in a funding round on March 29, 2019.
What does Enliven Therapeutics do?
Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better.
Where is Enliven Therapeutics based and how big is it?
Enliven Therapeutics is based in Burlingame, California, United States. Fundz records about 85 employees.
Who are the decision-makers at Enliven Therapeutics?
Fundz holds 1 contact at Enliven Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Science And Engineering around the same time

Companies in the same sectors as Enliven Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • MBX Biosciences, Inc. raised $23M on May 10, 2019.
  • Oncotelic Therapeutics raised $27M on May 7, 2019.
  • Oncotelic Therapeutics raised $600K (Seed) on May 7, 2019.
  • Sherlock Biosciences raised $33M on April 25, 2019.
  • DTx Pharma, Inc. raised $5.5M on April 23, 2019.
  • Korsana Biosciences raised $175M on April 17, 2019.

Who to call at Enliven Therapeutics, and when

A new round usually means Enliven Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Enliven Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Enliven Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Enliven Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Enliven Therapeutics

Location

205 Park Road

Burlingame, California, United States

About

Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights from clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Enliven Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts17 people are listed at Enliven Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Enliven Therapeutics's next move

See what Strategic adds

Enliven Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.